Jay Venkatesan's Insider Trades & SAST Disclosures
Jay Venkatesan's most recent trade in Elicio Therapeutics Inc. was a trade of 7,900 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on May 19, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Jay Venkatesan.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Elicio Therapeutics Inc. | Jay R. Venkatesan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2025 | 7,900 | 7,900 | - | - | Stock Option (Right to Buy) | |
| Elicio Therapeutics Inc. | Jay R. Venkatesan | Director | 26 Nov 2024 | 50,000 | 179,581 | - | 0.0 | 500 | Common Stock | |
| Elicio Therapeutics Inc. | Jay R. Venkatesan | Director | 26 Nov 2024 | 50,000 | 0 | - | - | Warrant to Purchase Common Stock | ||
| Elicio Therapeutics Inc. | Jay R. Venkatesan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Nov 2024 | 4,100 | 4,100 | - | - | Stock Option (Right to Buy) | |
| Elicio Therapeutics Inc. | Jay Venkatesan | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 28 Jun 2024 | 50,000 | 50,000 | - | - | Pre-Funded Warrants | |
| Elicio Therapeutics Inc. | Jay Venkatesan | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 28 Jun 2024 | 50,000 | 50,000 | - | - | Common Warrants | |
| Elicio Therapeutics Inc. | Jay Venkatesan | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 28 Jun 2024 | 50,000 | 50,000 | - | - | Pre-Funded Warrants | |
| Elicio Therapeutics Inc. | Jay Venkatesan | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 28 Jun 2024 | 50,000 | 50,000 | - | - | Common Warrants | |
| Elicio Therapeutics Inc. | Jay Venkatesan | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 28 Jun 2024 | 50,000 | 50,000 | - | - | Pre-Funded Warrants | |
| Elicio Therapeutics Inc. | Jay Venkatesan | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 28 Jun 2024 | 50,000 | 50,000 | - | - | Common Warrants | |
| Elicio Therapeutics Inc. | Jay Venkatesan | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 28 Jun 2024 | 50,000 | 50,000 | - | - | Pre-Funded Warrants | |
| Elicio Therapeutics Inc. | Jay Venkatesan | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 28 Jun 2024 | 50,000 | 50,000 | - | - | Common Warrants | |
| Elicio Therapeutics Inc. | Jay R. Venkatesan | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 28 Jun 2024 | 50,000 | 50,000 | - | - | Pre-Funded Warrants | |
| Elicio Therapeutics Inc. | Jay R. Venkatesan | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 28 Jun 2024 | 50,000 | 50,000 | - | - | Common Warrants | |
| Elicio Therapeutics Inc. | Venkatesan Jay | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Dec 2023 | 4,100 | 4,100 | - | - | Stock Option (right to buy) | |
| Alpine Immune Sciences Inc | Jay Venkatesan | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2022 | 20,063 | 70,000 | - | - | Stock Option (Right to buy) | |
| Alpine Immune Sciences Inc | Jay Venkatesan | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.45 per share. | 15 Jul 2022 | 20,063 | 238,126 (1%) | 0% | 0.4 | 9,028 | Common Stock |
| Alpine Immune Sciences Inc | Jay Venkatesan | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 10,000 | 10,000 | - | - | Stock Option (Right to buy) | |
| Alpine Immune Sciences Inc | Jay Venkatesan | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 9.40 per share. | 17 Sep 2021 | 400,000 | 2,600,980 (13%) | 2% | 9.4 | 3,760,000 | Common Stock |
| Alpine Immune Sciences Inc | Jay Venkatesan | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Mar 2021 | 7,650 | 0 | - | - | Stock Option (Right to buy) | |
| Alpine Immune Sciences Inc | Jay Venkatesan | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.09 per share. | 30 Mar 2021 | 7,650 | 210,413 (1%) | 0% | 4.1 | 31,289 | Common Stock |
| Alpine Immune Sciences Inc | Jay Venkatesan | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.62 per share. | 30 Mar 2021 | 7,650 | 218,063 (1%) | 0% | 3.6 | 27,718 | Common Stock |
| Alpine Immune Sciences Inc | Jay Venkatesan | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Mar 2021 | 7,650 | 0 | - | - | Stock Option (Right to buy) | |
| Alpine Immune Sciences Inc | Jay Venkatesan | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2021 | 7,650 | 7,650 | - | - | Stock Option (Right to buy) | |
| Alpine Immune Sciences Inc | Jay Venkatesan | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 22 Dec 2020 | 993,801 | 3,000,980 (16%) | 5% | 0 | Common Stock | |
| Alpine Immune Sciences Inc | Jay Venkatesan | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 22 Dec 2020 | 181,024 | 202,763 (1%) | 0% | 0 | Common Stock | |
| Exicure Inc | Jay Venkatesan | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jul 2020 | 12,930 | 0 | - | - | Stock Option (right to buy) | |
| Exicure Inc | Jay Venkatesan | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.03 per share. | 06 Jul 2020 | 12,930 | 324,473 (0%) | 0% | 1.0 | 13,318 | Common Stock |
| Exicure Inc | Jay Venkatesan | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.65 per share. | 06 Jul 2020 | 9,310 | 311,544 (0%) | 0% | 0.7 | 6,052 | Common Stock |
| Exicure Inc | Jay Venkatesan | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jul 2020 | 9,310 | 0 | - | - | Stock Option (right to buy) | |
| Exicure Inc | Jay Venkatesan | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2020 | 21,693 | 21,693 | - | - | Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges